Skip to content
value.today

Cagent Vascular, LLC

🇺🇸 Wayne, Pennsylvania, USAHealth CareFounded 2014
Total raised
$66 M
4 rounds on record
Latest round
$24 M
May 2026
First round on record
Jul 2017
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Cagent Vascular, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2026$24 MNo. 4$10 to $50 million

Cagent Vascular, LLC: Raise no. 4, May 2026

Investors in this round

51 investors had bought by the notice of Jun 5, 2026: 51 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$24 M of $41 M offered; $17 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aaron Green · Executive Officer · Secretary of Issuer
  • Brian Walsh · Executive Officer, Director · President of Issuer
  • Bruce Brumfield, Jr. · Director
  • Casey Tansey · Director
  • Marc-Andre Marcotte · Director
  • Tak Cheung · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brian Walsh, Chief Executive Officer of Issuer. Source: SEC Form D, newest notice filed Jun 5, 2026. Read the notice at the SEC.

equitySEC
Jan 2024$29 MNo. 3$10 to $50 million

Cagent Vascular, LLC: Raise no. 3, Jan 2024

Investors in this round

26 investors had bought by the notice of Feb 14, 2024: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$29 M of $30 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Carol A. Burns · Executive Officer, Director
  • Dennis A. McGrath · Executive Officer
  • Brian J Walsh · Director
  • Bruce J Blumfield · Director
  • Casey A. Tansey · Director
  • Marc-Andre J Marcotte · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Carol A. Burns, Ceo. Source: SEC Form D, newest notice filed Feb 14, 2024. Read the notice at the SEC.

equitySEC
Jun 2021$10 MNo. 2$2 to $10 million

Cagent Vascular, LLC: Raise no. 2, Jun 2021

Investors in this round

11 investors had bought by the notice of Jun 25, 2021: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Carol Burns · Executive Officer, Director
  • Dennis McGrath · Executive Officer, Director
  • Brian Walsh · Director
  • Fred Lampropoulos · Director
  • Marc-Andre Marcotte · Director
  • Mike Markert · Director
  • Peter Schneider · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Carol A. Burns, Ceo. Source: SEC Form D, newest notice filed Jun 25, 2021. Read the notice at the SEC.

equitySEC
Jul 2017$3 MNo. 1$2 to $10 million

Cagent Vascular, LLC: Raise no. 1, Jul 2017

Investors in this round

31 investors had bought by the notice of May 14, 2018: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $12 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Carol A. Burns · Executive Officer, Director
  • Dennis A. McGrath · Executive Officer, Director
  • Brian A. Walsh · Director
  • Fred A. Lampropoulos · Director
  • Peter A. Schneider · Director
  • Robert A. Giasolli · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Carol A. Burns, Chief Executive Officer and President. Source: SEC Form D, newest notice filed May 14, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Cagent Vascular, LLC chose not to state its revenue in its newest notice of a funding round (Jun 2026).

    SEC Form D · Jun 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jun 2026

That is all the official record says: Cagent Vascular, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Cagent Vascular, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 51 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Cagent Vascular, LLC
NameRoleNamed in
Aaron GreenSecretary of IssuerJun 2026
Brian WalshPresident of IssuerJun 2026
Carol A. BurnsExecutive officerFeb 2024
Dennis A. McGrathExecutive officerFeb 2024
Carol BurnsExecutive officerJun 2021
Dennis McGrathExecutive officerJun 2021
Brian WalshPresident of IssuerJun 2026
Bruce Brumfield, Jr.DirectorJun 2026
Casey TanseyDirectorJun 2026
Marc-Andre MarcotteDirectorJun 2026
Tak CheungDirectorJun 2026
Brian J WalshDirectorFeb 2024
Bruce J BlumfieldDirectorFeb 2024
Carol A. BurnsDirectorFeb 2024
Casey A. TanseyDirectorFeb 2024
Marc-Andre J MarcotteDirectorFeb 2024
Carol BurnsDirectorJun 2021
Dennis McGrathDirectorJun 2021
Fred LampropoulosDirectorJun 2021
Mike MarkertDirectorJun 2021
Peter SchneiderDirectorJun 2021
Brian A. WalshDirectorMay 2018
Dennis A. McGrathDirectorMay 2018
Fred A. LampropoulosDirectorMay 2018
Peter A. SchneiderDirectorMay 2018
Robert A. GiasolliDirectorMay 2018